Philips Respironics initiated a recall in March of 73,000 Trilogy Evo ventilators that were distributed in the US between March 2019 and March 2023. Recalled products include the Trilogy Evo, Trilogy Evo O2, Trilogy EV300, and Trilogy Evo Universal.
Death, Injuries Linked To Recalled Philips Ventilators
Company Says Reported Death Being Investigated
Philips recalled thousands of Trilogy Evo ventilators in March. The US FDA has designated the recall class I, its most serious type.
More from Regulation
• By
Pediatric devices and IVDs are to be a priority. And the European Health Data Space regulation is seen as critical in supporting digital technologies and AI in transforming care.
• By
As deadlines approach, the regulatory landscape for medtech batteries is set to change, with an emphasis on sustainability and ethical practices.
The Doctor Patient Forum says the US FDA should regulate a scoring platform from Bamboo Health intended to help clinicians calculate risk for opioid abuse as a medical device to ensure patient safety.
• By
EU medtech trade associations present detailed arguments for the European Commission’s 'targeted evaluation' of medtech regulations, highlighting the need for immediate course correction.
More from Policy & Regulation
• By
Stakeholders are pleading for newly confirmed FDA Commissioner Martin Makary to stand up for the agency's high scientific standards and staff as he begins his term.
• By
People living with diabetes who receive continuous glucose monitors (CGMs) through medical supply firms show higher compliance, lower costs of care, and fewer hospitalizations after one year than those who use pharmacies, a new study shows.
• By
Pediatric devices and IVDs are to be a priority. And the European Health Data Space regulation is seen as critical in supporting digital technologies and AI in transforming care.